NCT00299650 Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients Status COMPLETED Phase PHASE4
NCT00299286 Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer Status COMPLETED Phase PHASE2
NCT00298155 Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT00297856 Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine Status COMPLETED Phase N/A
NCT00297258 Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00297206 A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children Status COMPLETED Phase PHASE1
NCT00297180 Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks Status COMPLETED Phase PHASE2
NCT00297076 Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects Status TERMINATED Phase PHASE3
NCT00297063 BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy- Status COMPLETED Phase PHASE3
NCT00297011 Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis Status COMPLETED Phase PHASE2
NCT00296517 Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors Status COMPLETED Phase PHASE3
NCT00296504 A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects Status COMPLETED Phase PHASE3
NCT00296491 Study Of Allergic Rhinitis In Patients Who Also Have Asthma Status COMPLETED Phase PHASE4
NCT00295776 Lamictal in the Treatment of Post-Herpetic Neuralgia Status TERMINATED Phase PHASE2/PHASE3
NCT00295243 Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT00294190 Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer Status COMPLETED Phase PHASE2